Breaking News: BioELife Corp Expands Coronavirus (COVID-19) Prevention Product Line and Receives Purchase Order from New Distributor | Financial Buzz

Breaking News: BioELife Corp Expands Coronavirus (COVID-19) Prevention Product Line and Receives Purchase Order from New Distributor

BioELife Corp. (OTC: LITH) (the “Company”), is pleased to announce that it continues to achieve several key objectives for Q1 2020. The Company received a purchase order from a new distributor for the next production run of its entire product line including back-ordered BioEDefense products recently launched to help the world-wide crisis surrounding the Coronavirus (COVID-19). The Company has added the RespiPro Virus Killer nanofiber mask to its ecommerce site while ordering additional inventory for the BioEDefense line of products with expected delivery in April. The Company has also received pre-orders on its new packaging option of ChiroRub 2000 – a 3 ml singe use packette. All BioELife products are available for order and preorder on the Company’s ecommerce website,  

The initial purchase order from Group Buying Club- GPOCBD, covers all current BioELife products – lotions, tinctures, flower and gummies as well as the BioEDefense product line: Sanitizers, RespiPro Virus Killer Masks, and the R-Shield (a reusable nanofiber scarf designed for 50 wash cycles). GPOCBD is marketing CBD products directly to wholesalers, consumers and affiliates looking to supplement their sales of BioELife products which offer natural products to fight pain and infection, as well as help defend against the growing global concerns regarding bacteria and virus’s contamination.

Due to the level of preorders at, the Company continues to increase its sales projections and place additional manufacturing orders to ensure adequate supply lines. Furthermore, the Company continues to identify additional sales channels for the nanofiber copper lined masks which are far superior to traditional surgical masks used by doctors and hospital personnel. The Company expects further announcements as it captures a significant market share with the BioEDefense product line.

Gregory Rotelli, Chairman of the Board and President of BioELife Corp stated “We continue to grow our product line, research & development partnerships, and sales channels as we position BioELife as the leading manufacturer and distributor of CDB products that help improve people’s lives with natural solutions for pain, stress and anxiety. Additionally, we are accelerating our product release schedules to grow our BioEDefense line of products that help people defend against the worldwide threat of viral and bacterial contamination. We will continue to analyze where we can make a difference and help improve people’s lives through the use of non-addictive relief products. We also expect to announce further enhancements to our BioEDefense product line which is focused on defending against and fighting the current Covid-19 outbreak, and potential future threats, which cause immense harm to individuals and economies across the globe.”

About the Company

BioELife Corp was created by successful pharmaceutical entrepreneurs dedicated to using nature’s resources to fight pain and infection while reducing the dependency on opioids and their terrible side effects. The Company is uniquely positioned to capitalize on the emerging Cannabinoid market that is growing at phenomenal rates and is expected to reach $20 Billion over the next five years. The Company has created a ‘seed to shelf’ value-added product development and marketing organization with direct contracts for raw materials, scientific proprietary formulation, manufacturing, and distribution of medically focused Cannabinoid products. Additionally, the Company has a BioEDefense line of products that provide advanced protection from virus and bacteria contamination.

Sponsored Content Release. Click for Full Disclosure

  • Sponsored Content Release, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For bioelife corp. financial and corporate news dissemination, has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: